KADYN BROOKS: Open Payments
NPI 1912776188 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 12 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $165 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC | 4 | $146 |
| Eisai Inc. | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 1 | $50 |
| Alexion Pharmaceuticals, Inc. | 1 | $41 |
| Amgen Inc. | 1 | $35 |
| Lundbeck LLC | 1 | $18 |
| ARGENX US, INC. | 1 | $16 |
Products named: CREXONT, Leqembi, WAINUA, KOSELUGO, UPLIZNA, VYEPTI, VYVGART HYTRULO.
Industry payments across LA — which companies pay providers there.
